ANGIODYNAMICS INC

AngioDynamics designs, manufactures, and sells medical devices for vascular intervention, oncology, and surgical applications. The company's portfolio spans several therapeutic areas, including peripheral vascular disease treatment through systems like the Auryon Atherectomy platform for lesion removal and the AlphaVac mechanical thrombectomy system for clot elimination. Its thrombus management offerings include thrombolytic catheters and the AngioVac venous drainage cannula for extracorporeal circulatory support. The company also manufactures the NanoKnife IRE Ablation System for soft tissue ablation, the VenaCure EVLT system for endovascular laser treatment of venous disease, and the Solero Microwave Tissue Ablation System.

Supporting its intervention platforms, AngioDynamics produces peripheral products including angiographic catheters, guidewires, and micro-introducer kits used in diagnostic and interventional procedures. The company's drainage portfolio encompasses abscession, nephrostomy, and biliary drainage catheters, alongside micro-access kits designed for minimally invasive interventional techniques.

Headquartered in Latham, New York, AngioDynamics operates with approximately 675 full-time employees and maintains an international presence. The company was incorporated in Delaware and trades on Nasdaq. Founded in 1988, it serves healthcare providers across the United States and internationally.